PTC Therapeutics, Inc.

PTC Therapeutics, Inc.verified

PTCT

Price:

$45.56

Market Cap:

$3.51B

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra...[Read more]

Industry

Biotechnology

IPO Date

2013-06-20

Stock Exchange

NASDAQ

Ticker

PTCT

The Enterprise Value as of December 2024 (TTM) for PTC Therapeutics, Inc. (PTCT) is 3.39B

According to PTC Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.39B. This represents a change of 53.61% compared to the average of 2.21B of the last 4 quarters.

PTC Therapeutics, Inc. (PTCT) Historical Enterprise Value (quarterly & annually)

How has PTCT Enterprise Value performed in the past?

The mean historical Enterprise Value of PTC Therapeutics, Inc. over the last ten years is 2.04B. The current 3.39B Enterprise Value has changed 16.49% with respect to the historical average. Over the past ten years (40 quarters), PTCT's Enterprise Value was at its highest in in the December 2020 quarter at 4.42B. The Enterprise Value was at its lowest in in the December 2016 quarter at 239.33M.

Quarterly (TTM)
Annual

Average

2.04B

Median

1.99B

Minimum

237.98M

Maximum

4.24B

PTC Therapeutics, Inc. (PTCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PTC Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 552.05%

Maximum Annual Enterprise Value = 4.24B

Minimum Annual Increase = -71.83%

Minimum Annual Enterprise Value = 237.98M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20233.70B22.00%
20223.03B22.97%
20212.46B-41.89%
20204.24B72.80%
20192.45B61.06%
20181.52B151.45%
2017606.06M154.67%
2016237.98M-71.83%
2015844.93M-35.94%
20141.32B552.05%

PTC Therapeutics, Inc. (PTCT) Average Enterprise Value

How has PTCT Enterprise Value performed in the past?

The current Enterprise Value of PTC Therapeutics, Inc. (PTCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.06B

5-year avg

3.18B

10-year avg

2.04B

PTC Therapeutics, Inc. (PTCT) Enterprise Value vs. Peers

How is PTCT’s Enterprise Value compared to its peers?

PTC Therapeutics, Inc.’s Enterprise Value is less than Krystal Biotech, Inc. (4.25B), less than Sarepta Therapeutics, Inc. (12.73B), greater than Iovance Biotherapeutics, Inc. (2.19B), less than Madrigal Pharmaceuticals, Inc. (6.67B), less than Reata Pharmaceuticals, Inc. (6.64B), greater than Intercept Pharmaceuticals, Inc. (915.81M), less than Blueprint Medicines Corporation (6.12B), less than Viking Therapeutics, Inc. (0), less than Hepion Pharmaceuticals, Inc. (4.67B), greater than null (4.20M),

Build a custom stock screener for PTC Therapeutics, Inc. (PTCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PTC Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PTC Therapeutics, Inc. (PTCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PTC Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is PTC Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for PTC Therapeutics, Inc. (PTCT)?

What is the 3-year average Enterprise Value for PTC Therapeutics, Inc. (PTCT)?

What is the 5-year average Enterprise Value for PTC Therapeutics, Inc. (PTCT)?

How does the current Enterprise Value for PTC Therapeutics, Inc. (PTCT) compare to its historical average?